The potential importance of PD-L1 expression by infiltrating immune cells [17], the presence and location of CD8+ tumour-infiltrating lymphocytes [35], and other factors in the tumour immune microenvironment [36] are currently being studied to discern more sensitive and specific predictors of clinical outcomes. Here, CD8A is linked to neoplasm.